Vorhofflimmern

Schlüsselwörter

Vorhofflimmern - Antiarrhythmika - Katheterablation - Antikoagulation

Schlüsselwörter

atrial fibrillation - antiarrhythmic drug - catheter ablation - anticoagulation

Literatur

• 1 Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.  J Am Coll Cardiol. 2003;  42 20-29
• 2 Alboni P, Botto G L, Baldi N. et al . Outpatient treatment of recent-onset atrial fibrillation with the „pill-in-the-pocket” approach.  N Engl J Med. 2004;  351 2384-2391
• 3 Cappato R, Calkins H, Chen S A. et al . Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.  Circulation. 2005;  111 1100-1105
• 4 Chung M K, Shemanski L, Sherman D G. et al . Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.  J Am Coll Cardiol. 2005;  46 1891-1899
• 5 Cox J L, Jaquiss R D, Schuessler R B, Boineau J P. Modification of the Maze procedure for atrial flutter and atrial fibrillation.  J Thorac Cardiovasc Surg. 1995;  110 485-495
• 6 Crijns H J, Van Gelder I C, Van Gilst W H. et al . Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.  Am J Cardiol. 1991;  68 335-341
• 7 Flaker G C, Blackshear J L, McBride R. et al . Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.  J Am Coll Cardiol. 1992;  20 527-532
• 8 Fuster V, Ryden L E, Cannom D S. et al . ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines: developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.  Circulation. 2006;  114 e257-e354
• 9 Gage B F, Waterman A D, Shannon W. et al . Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.  JAMA. 2001;  285 2864-2870
• 10 Goette A, Lendeckel U, Klein H U. Molecular biology of the heart atrium. New insights into the pathophysiology of atrial fibrillation as well as its clinical implications.  Z Kardiol. 2004;  93 864-877
• 11 Haissaguerre M, Jais P, Shah D C. et al . Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulomonary veins.  N Engl J Med. 1998;  339 659-666
• 12 Hart R G, Benavente O, McBride R, Pearce L A. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.  Ann Intern Med. 1999;  131 492-501
• 13 Hohnloser S, Kuck K H, Lielenthal J. Rhythm or rate control in atrial fibrillation - pharmacological intervention in atrial fibrillation (PIAF): a randomised trial.  Lancet. 2000;  356 1789-1794
• 14 Julian D G, Camm A J, Frangin G. et al . Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT.  Lancet. 1997;  349 667-674
• 15 Kistler P M, Rajappan K, Jahngir M. et al . The impact of CT image integration into an electroanatomic mapping system on clinical outcomes of catheter ablation of atrial fibrillation.  J Cardiovasc Electrophysiol. 2006;  17 1093-1101
• 16 Kopecky S L, Gersh B J, McGoon M D. et al . The natural history of lone atrial fibrillation: a population-based study over three decades.  N Engl J Med. 1987;  317 669-674
• 17 Kottkamp H, Hindricks G, Autschbach R. et al . Specific linear left atrial lesions in atrial fibrillation: intraoperative radiofrequency ablation using minimally invasive surgical techniques.  J Am Coll Card. 2002;  40 475-480
• 18 Kühlkamp V, Mermi J, Mewis C, Seipel L. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.  J Cardiovasc Pharmacol. 1997;  29 373-381
• 19 Kühlkamp V, Schirdewan A, Stangl K. et al . Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation.  J Am Coll Card. 2000;  36 139-146
• 20 Neuberger H R, Schotten U, Verheule S. et al . Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat.  Circulation. 2005;  111 30-37
• 21 Olshansky B, Heller E N, Mitchell L B. et al . Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study.  J Am Coll Cardiol. 2005;  45 2026-2033
• 22 Oral H, Scharf C, Chugh A. et al . Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation.  Circulation. 2003;  108 2355-2360
• 23 Ouyang F, Antz M, Ernst S. et al . Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique.  Circulation. 2005;  111 127-135
• 24 Page R L, Tilsch T W, Connolly S J. et al . Asymptomatic or „silent” atrial fibrillation: frequency in untreated patients and patients receiving azimilide.  Circulation. 2003;  107 1141-1145
• 25 Roy D, Talajic M, Dorian P. et al . The Canadian Trial of Atrial Fibrillation Investigators. Amiodarone to Prevent Recurrence of Atrial Fibrillation.  N Engl J Med. 2000;  342 913-920
• 26 The cardiac arrhythmia suppression trial (CAST) investigators . Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.  N Engl J Med. 1989;  321 406-412
• 27 Van Gelder I C, Hagens V E, Bosker H A. et al . A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.  N Engl J Med. 2002;  347 1834-1840
• 28 Wazni O M, Marrouche N F, Martin D O. et al . Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.  JAMA. 2005;  293 2634-2640
• 29 Wijffels M C, Kirchhof C J, Dorland R, Allessie M A. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats.  Circulation. 1995;  92 1954-1968
• 30 Wyse D G, Waldo A L, DiMarco J P. et al . A comparison of rate control and rhythm control in patients with atrial fibrillation.  N Engl J Med. 2002;  347 1825-1833